Select publications

Corvo R et al. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: Rationale, preliminary results and perspectives. Tumori 2003;89(4):361-7. Abstract

de Gramont A et al. Oxaliplatin/5-FU/LV in adjuvant colon cancer: Results of the international randomized MOSAIC trial. Proc ASCO 2003;Abstract 1015.

Dunst J et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 2002;20(19):3983-91. Abstract

Hyams DM et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum 1997;40(2):131-9. Abstract

Lin EH et al. A phase II study of capecitabine and radiotherapy plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC): Preliminary safety analysis. Proc ASCO 2003;Abstract1152.

Maung K. Integrating oxaliplatin and capecitabine in adjuvant therapy of high-risk colorectal cancer. Clin Colorectal Cancer 2003;3(3):150-3. Abstract

Pfeiffer P et al. Short-time infusion of oxaliplatin (Eloxatin) in combination with capecitabine (Xeloda) in patients with advanced colorectal cancer. Acta Oncol 2003;42(8):832-6. Abstract

Rodel C et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003;21(16):3098-104. Abstract

Scheithauer W et al. Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2003;21(7):1307-12. Abstract

Souglakos J et al. Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. Int J Radiat Oncol Biol Phys 2003;56(5):1284-7. Abstract

Twelves C. Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer? Oncology (Huntingt) 2002;16(12 Suppl No 14):23-6. Abstract

Van Cutsem E et al. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer. 2004 Mar 22;90(6):1190-7. Abstract

Zeuli M et al. Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Ann Oncol 2003;14(9):1378-82. Abstract